|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3-4
|
|
pubmed:dateCreated |
2002-5-13
|
|
pubmed:abstractText |
Epidemiologic and auxologic characteristics of patients treated with GH during childhood and adolescence and entered in a national registry in Catalonia were studied between 1988 and 1997. At the end of 1997, prevalence was 53.2 treatments/100,000 inhabitants aged 0-14 years. Maximum annual incidence rates were observed in 1990 and 1991 (34.0-35.6 cases/100,000 inhabitants aged 0-14 years).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0301-0163
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2002 S. Karger AG, Basel
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
57
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
113-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12006707-Adolescent,
pubmed-meshheading:12006707-Body Height,
pubmed-meshheading:12006707-Child,
pubmed-meshheading:12006707-Cross-Sectional Studies,
pubmed-meshheading:12006707-Female,
pubmed-meshheading:12006707-Growth Disorders,
pubmed-meshheading:12006707-Human Growth Hormone,
pubmed-meshheading:12006707-Humans,
pubmed-meshheading:12006707-Male,
pubmed-meshheading:12006707-Regression Analysis,
pubmed-meshheading:12006707-Retrospective Studies,
pubmed-meshheading:12006707-Time Factors,
pubmed-meshheading:12006707-Treatment Outcome
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Long-Term GH therapy: epidemiology and auxologic outcome.
|
|
pubmed:affiliation |
Growth Hormone and Related Substances Utilization Advisory Council, Catalan Health Service, Barcelona, Spain. laudi@cs.vhebron.es
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Multicenter Study
|
